高渗盐水、甘露醇及甘露醇联合甘油在重型创伤性脑损伤患者中单次负荷剂量的比较研究
这项前瞻性随机对照研究将120例重型创伤性脑损伤合并颅内压升高的患者随机分组,分别接受等渗透摩尔、等容积剂量的3%高渗盐水、20%甘露醇及10%甘露醇联合10%甘油,以颅内压降至15 mmHg以下为停止输注标准。三种药物均能有效降低颅内压,3%高渗盐水在最大颅内压降幅、平均动脉压与脑灌注压提升、减少所需剂量及缩短起效时间方面表现更优。
要点
- 三种渗透性药物均能将颅内压降至15 mmHg以下(P < 0.0001)。
- 3%高渗盐水降低颅内压的最大变化为60%,10%甘露醇联合10%甘油为57%,20%甘露醇为55%。
- 将颅内压降至15 mmHg以下的平均剂量:3%高渗盐水1.4 mL/kg,10%甘露醇联合10%甘油1.7 mL/kg,20%甘露醇2.0 mL/kg。
核心结论
- 在给予相似渗透负荷时,三种渗透性药物降低颅内压的有效性相当,但3%高渗盐水似乎更有效,其次为10%甘露醇联合10%甘油,再次为20%甘露醇。
- 作者推荐1.4 mL/kg可作为3%高渗盐水的初始单次负荷剂量。
- 作者推荐高渗盐水可用于治疗治疗前存在低血容量、低钠血症或肾功能衰竭的患者。
- 与20%甘露醇相比,在神经功能结局方面无明确获益,尽管3%高渗盐水和10%甘露醇联合10%甘油有轻微积极趋势。
研究设计与样本
- 前瞻性随机对照研究,纳入120例年龄>18岁、格拉斯哥昏迷评分≤8、颅内压>20 mmHg持续超过5分钟的重型创伤性脑损伤患者。
- 患者随机接受等渗透摩尔、等容积剂量的3%高渗盐水、20%甘露醇或10%甘露醇联合10%甘油,以规定输注速率给药,当颅内压<15 mmHg时停止输注。
- 采用单因素方差分析比较组间效应,Tukey法进行多重比较,配对t检验分析组内用药效应。
主要发现
- 所有3种药物均将颅内压降至15 mmHg以下(P < 0.0001)。
- 颅内压最大变化:3%高渗盐水60% vs 10%甘露醇联合10%甘油57% vs 20%甘露醇55%。
- 平均动脉压和脑灌注压在单次负荷剂量后升高,最大变化出现在3%高渗盐水输注后,其次为10%甘露醇联合10%甘油和20%甘露醇(P < 0.0349和P < 0.0013)。
- 任何研究药物单次负荷剂量后血细胞比容值均无统计学显著变化。
- 血清钠和渗透压在校正后显著升高,最大变化出现在3%高渗盐水单次负荷剂量后。
临床怎么用
- 作者推荐1.4 mL/kg可作为3%高渗盐水的初始单次负荷剂量。
- 作者推荐高渗盐水可用于治疗治疗前存在低血容量、低钠血症或肾功能衰竭的患者。
- 作者指出与20%甘露醇相比,在神经功能结局方面无明确获益,尽管3%高渗盐水和10%甘露醇联合10%甘油有轻微积极趋势。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This prospective randomized controlled study compared the efficacy of an equiosmolar and isovolumetric dose of 3% hypertonic saline, 20% mannitol, and 10% mannitol plus 10% glycerol combination in reducing the raised intracranial pressure (ICP) in patients with severe traumatic brain injury (TBI). METHODS: A total of 120 patients of severe TBI with increased ICP were randomized to receive an equiosmolar and isovolumetric dose of 3% hypertonic saline, 20% mannitol, and 10% mannitol plus 10% glycerol combination at a defined infusion rate, which was stopped when ICP was <15 mm Hg. RESULTS: A total of 120 patients with severe TBI (aged >18 years, Glasgow Coma Scale ≤8, and had sustained elevated ICP of >20 mm Hg for more than 5 minutes) were randomized during the study. All data were presented as mean (minimum-maximum). A one-way analysis of variance test was used to analyze the effect across the treatment group, and Tukey's method was used for multiple comparisons. A paired t-test was employed to analyze the effect of the medication within each group. All 3 drugs decreased ICP below 15 mm Hg (P < 0.0001). The maximum change in ICP occurred after a bolus dose of 3% hypertonic saline followed by 10% mannitol plus 10% glycerol combination and then 20% mannitol (60% vs. 57% vs. 55%, respectively). Mean arterial pressure and cerebral perfusion pressure were increased after the bolus dose of study medications. Maximum changes occurred after infusion of 3% hypertonic saline followed by 10% mannitol plus 10% glycerol combination and 20% mannitol (P < 0.0349 and <0.0013, respectively). There was no statistically significant change in the hematocrit value noted after the bolus dose of any of the study medications. Serum sodium and osmolarity were raised significantly after the bolus dose of study medications. Maximum changes in serum sodium and osmolarity occurred after the bolus dose of 3% hypertonic saline. The mean dose required to reduce ICP below 15 mm Hg for 3% hypertonic saline: 1.4 mL/kg, for 10% mannitol plus 10% glycerine: 1.7 mL/kg, and for 20% mannitol: 2.0 mL/kg. The mean time required to reduce ICP below 15 mm Hg for 3% hypertonic saline: 16 minutes, for 10% mannitol plus 10% glycerine: 19 minutes, and for 20% mannitol: 23 minutes. The maximum change in the Glasgow Coma Scale occurred after the bolus dose of 3% hypertonic saline, followed by 10% mannitol plus 10% glycerol combination and then 20% mannitol. CONCLUSIONS: All 3 osmotic compounds exhibit comparable effectiveness in reducing ICP when a similar osmotic load is administrated, but 3% hypertonic saline appeared to be more effective followed by 10% mannitol plus 10% glycerol combination and 20% mannitol. A dose of 1.4 mL/kg can be recommended as an initial bolus dose for 3% hypertonic saline. Hypertonic saline can be recommended to treat patients with pretreatment hypovolemia, hyponatremia, or renal failure. There is no clear benefit compared with 20% mannitol in regard to neurologic outcome, even though there is a minor positive trend for 3% hypertonic saline and 10% mannitol plus 10% glycerol combination.
引用
- Patil H, Gupta R. A Comparative Study of Bolus Dose of Hypertonic Saline, Mannitol, and Mannitol Plus Glycerol Combination in Patients with Severe Traumatic Brain Injury. World Neurosurg. 2019. PMID: 30684710. doi:10.1016/j.wneu.2019.01.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。